Literature DB >> 10027952

Goodpasture syndrome.

R Kalluri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027952     DOI: 10.1046/j.1523-1755.1999.0550031120.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  7 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

2.  Uveitis initiating an autoimmune reaction resulting in Goodpasture's syndrome in a Chinese man.

Authors:  M Chak; M R Stanford; W Poon; E M Graham; M F Tungekar; D Goldsmith
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

3.  Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.

Authors:  Brian A MacDonald; Malin Sund; Marianne A Grant; Kathleen L Pfaff; Kathryn Holthaus; Leonard I Zon; Raghu Kalluri
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

4.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

Review 5.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

Review 6.  Renal complications of seasonal and pandemic influenza A virus infections.

Authors:  Toru Watanabe
Journal:  Eur J Pediatr       Date:  2012-10-13       Impact factor: 3.183

7.  Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease.

Authors:  A Nakamura; T Yuasa; A Ujike; M Ono; T Nukiwa; J V Ravetch; T Takai
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.